Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction

por Chen, Yue, Xu, Yu-ying, Jiang, Hai-jun, Wang, Lei, Zhai, Jia-wei, Zhang, Tong, Yang, Yu-fei
Publicado 2022